{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:23:40Z","timestamp":1715646220872},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.2169\/internalmedicine.1275-22","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T22:13:22Z","timestamp":1675808002000},"page":"2747-2751","source":"Crossref","is-referenced-by-count":1,"title":["Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy"],"prefix":"10.2169","volume":"62","author":[{"given":"Hideki","family":"Oka","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Kobe City Medical Center General Hospital, Japan"},{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Sumitomo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kobe City Medical Center General Hospital, Japan"},{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Kanamori","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Urology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Connors GR, Christopher-Stine L, Oddis CV, Donoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138: 1464-1474, 2010.","DOI":"10.1378\/chest.10-0180"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77: 1019-1038, 1990.","DOI":"10.1093\/qjmed\/77.1.1019"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304: 177-179, 1983.","DOI":"10.1038\/304177a0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hervier B, Meyer A, Dieval C, et al. Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J 42: 1271-1282, 2013.","DOI":"10.1183\/09031936.00156312"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Seeger W, Adir Y, Barber\u00e0 JA, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 62: D109-D116, 2013.","DOI":"10.1016\/j.jacc.2013.10.036"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53: 1801913, 2019.","DOI":"10.1183\/13993003.01913-2018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179: 151-157, 2009.","DOI":"10.1164\/rccm.200806-953OC"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yang H, Peng Q, Yin L, et al. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19: 259, 2017.","DOI":"10.1186\/s13075-017-1469-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 12: 210-217, 2012.","DOI":"10.1016\/j.autrev.2012.06.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Opinc AH, Makowska JS. Antisynthetase syndrome - much more than just a myopathy. Semin Arthritis Rheum 51: 72-83, 2021.","DOI":"10.1016\/j.semarthrit.2020.09.020"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamakawa H, Yoshida M, Yamada M, et al. Pulmonary tumor thrombotic microangiopathy associated with urothelial carcinoma of the urinary bladder: antemortem diagnosis by pulmonary microvascular cytology. Clin Case Rep 3: 735-739, 2015.","DOI":"10.1002\/ccr3.330"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Garc\u00eda-Fern\u00e1ndez A, Quezada-Loaiza CA, de la Puente-Bujidos C. Antisynthetase syndrome and pulmonary hypertension: report of two cases and review of the literature. Mod Rheumatol Case Rep 5: 152-155, 2021.","DOI":"10.1080\/24725625.2020.1794521"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Taniguchi Y, Horino T, Kato T, Terada Y. Acute pulmonary arterial hypertension associated with anti-synthetase syndrome. Scand J Rheumatol 39: 179-180, 2010.","DOI":"10.3109\/03009740903270615"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Er\u00e7en Diken \u00d6, \u00c7ileda\u011f A, K\u00fc\u00e7\u00fck\u015fahin O, Kumbasar \u00d6\u00d6. Pulmonary arterial hypertension in antisynthetase syndrome without myositis. Tuberk Toraks 61: 170-173, 2013.","DOI":"10.5578\/tt.5042"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Handa T, Nagai S, Kawabata D, et al. Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med 44: 319-325, 2005.","DOI":"10.2169\/internalmedicine.44.319"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chatterjee S, Farver C. Severe pulmonary hypertension in anti-Jo-1 syndrome. Arthritis Care Res (Hoboken) 62: 425-429, 2010.","DOI":"10.1002\/acr.20109"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, et al. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford) 56: 999-1007, 2017.","DOI":"10.1093\/rheumatology\/kex021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Casta\u00f1eda-Pomeda M, Prieto-Gonz\u00e1lez S, Grau JM. Antisynthetase syndrome and malignancy: our experience. J Clin Rheumatol 17: 458, 2011.","DOI":"10.1097\/RHU.0b013e31823b1878"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rozelle A, Trieu S, Chung L. Malignancy in the setting of the anti-synthetase syndrome. J Clin Rheumatol 14: 285-288, 2008.","DOI":"10.1097\/RHU.0b013e31817d116f"},{"key":"20","unstructured":"20. Legault D, McDermott J, Crous-Tsanaclis AM, Boire G. Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. J Rheumatol 35: 169-171, 2008."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Boleto G, Perotin JM, Eschard JP, Salmon JH. Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature. Rheumatol Int 37: 1203-1206, 2017.","DOI":"10.1007\/s00296-017-3728-z"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Sanchez O, Sitbon O, Ja\u00efs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130: 182-189, 2006.","DOI":"10.1378\/chest.130.1.182"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1275-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:28:49Z","timestamp":1715574529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1275-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":22,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1275-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"1275-22"}}